Tokyo, May 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061621) titled 'Flutemetamol PET/CT for whoLe-body evalUation of amyloid deposiTion and its systEmic distribution' on May 20.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Kyoto Prefectural University of Medicine
Condition:
Condition - Mild Cognitive Impairment and Alzheimer's Disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To exploratorily evaluate the distribution and extent of amyloid deposition in whole-body organs, including the b...